Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04815018 · ClinicalTrials.gov registry record
Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2
A clinical trial, sponsored by Pathnostics.
- Terminated
- Registry status
- 185
- Enrollment target
NCT04815018: Clinical Trial study, sponsored by Pathnostics.
NCT04815018 is a clinical trial that was terminated before completion, run by Pathnostics. The registered enrollment target is 185 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04815018 was terminated before completion, sponsored by Pathnostics.
- TERMINATED
- Registry status
- 185 participants
- Enrollment target
Study Summary
This is a longitudinal, prospective observational study focusing on health-related outcomes relative to potential changes in the respiratory microbiome seen with weekly SARS-CoV-2 testing in nursing home residents.
Primary Outcome
Examine prospective data to determine the change from baseline (week 1 of testing) in resident/bed ratio positive for SARS-CoV-2.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2020-10-07 |
| Est. Completion | 2021-05-30 |
Why NCT04815018 stopped before completion
NCT04815018 is an observational study that tracks outcomes without assigning an intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04815018 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04815018 about?
NCT04815018 is a clinical study titled "Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2". This is a longitudinal, prospective observational study focusing on health-related outcomes relative to potential changes in the respiratory microbiome seen with weekly SARS-CoV-2 testing in nursing home residents.
What is the current status of trial NCT04815018?
This trial is currently terminated. The enrollment target is 185 participants. The study started on 2020-10-07. Estimated completion is 2021-05-30.
Who is sponsoring clinical trial NCT04815018?
This trial is sponsored by Pathnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI